Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Infant lung function and maternal physical activity in the first half of pregnancy

Hrefna Katrín Gudmundsdóttir, Oda C.L. Carlsen, Karen Eline Stensby Bains, Martin Färdig, Guttorm Haugen, Christine M. Jonassen, Marissa LeBlanc, Björn Nordlund, Eva Maria Rehbinder, Håvard O. Skjerven, Anne Cathrine Staff, Riyas Vettukattil, Karin C. Lødrup Carlsen
ERJ Open Research 2022 8: 00172-2022; DOI: 10.1183/23120541.00172-2022
Hrefna Katrín Gudmundsdóttir
1Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
2Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hrefna Katrín Gudmundsdóttir
  • For correspondence: h.k.gudmundsdottir@medisin.uio.no
Oda C.L. Carlsen
2Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Eline Stensby Bains
1Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
2Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Färdig
3Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden
4Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guttorm Haugen
1Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
5Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine M. Jonassen
6Genetic Unit, Centre for Laboratory Medicine, Østfold Hospital Trust, Kalnes, Norway
7Department of Virology, Norwegian Institute of Public Health, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marissa LeBlanc
8Oslo Centre of Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Björn Nordlund
3Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden
4Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Björn Nordlund
Eva Maria Rehbinder
1Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
9Department of Dermatology and Venereology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Håvard O. Skjerven
1Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
2Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Håvard O. Skjerven
Anne Cathrine Staff
1Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
5Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Riyas Vettukattil
1Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
2Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karin C. Lødrup Carlsen
1Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
2Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background and aim Physical activity (PA) in pregnancy is important for maternal and possibly offspring health. To study the early origins of lung function we aimed to determine whether PA in the first half of pregnancy is associated with lung function in healthy 3-month-old infants.

Methods From the general population-based Preventing Atopic Dermatitis and Allergies in Children birth cohort recruiting infants antenatally in Norway and Sweden, all 812 infants (48.8% girls) with available tidal flow–volume measures in the awake state at 3 months of age and mid-pregnancy data on PA were included. PA was self-reported by the mothers and, based on intensity, we categorised them as active or inactive during pregnancy. Furthermore, we defined active mothers as fairly or highly active. The main outcome was a ratio of time to peak tidal expiratory flow to expiratory time (tPTEF/tE) <0.25. Associations were analysed by logistic regression, adjusting for maternal age, education, parity, pre-pregnancy body mass index, in utero nicotine exposure and parental atopy.

Results The mean±sd tPTEF/tE was 0.391±0.08 and did not differ significantly according to maternal PA level in pregnancy. The 290 infants of inactive mothers had higher odds of having tPTEF/tE <0.25 compared to infants of all active mothers (OR 2.07, 95% CI 1.13–3.82; p=0.019) and compared to infants (n=224) of fairly active (OR 2.83, 95% CI 1.26–7.24; p=0.018) but not highly active mothers (n=298).

Conclusion Based on self-reported maternal PA in the first half of pregnancy, 3-month-old infants of inactive compared to active mothers had higher odds of a low tPTEF/tE.

Abstract

There is an association between self-reported maternal physical activity in the first half of pregnancy and lung function in healthy 3-month-old infants, with higher odds of low lung function among infants of inactive compared to active mothers https://bit.ly/3BVVv39

Introduction

Impaired infant lung function precedes wheezing and asthma both in childhood [1–3] and adulthood [4] as well as persistently lower lung function values [5, 6], suggesting that asthma likely originates in early life. Development of the respiratory system starts in the first weeks of fetal life [6, 7], and both genetics and the intrauterine environment impact lung function at birth [8].

Regular physical activity (PA) is an important contributor to a healthy lifestyle and is recommended during pregnancy in many countries [9, 10]. Staying physically active during pregnancy is safe for the fetus [11, 12], beneficial for maternal wellbeing, and reduces the risk of pregnancy complications [13–17] and the risk of caesarean deliveries in nonobese women [13, 14, 18]. For healthy women, PA in pregnancy is not associated with preterm delivery [10, 12–14] or abnormal birth weight [12, 13]. Accordingly, Norwegian guidelines recommend ≥150 min moderate or high intensity PA per week [19] although many women do not meet these recommendations [20]. However, the potential impact of maternal PA on early fetal airways and lung development is not clear.

Tidal flow–volume (TFV) loops in awake or naturally sleeping infants is a feasible method to measure lung function from the first day of life. The TFV ratio of time to peak tidal expiratory flow to expiratory time (tPTEF/tE) is a measure of expiratory airflow that correlates with maximal flow at functional residual capacity, using the rapid thoracoabdominal compression technique in sedated infants [5, 21]. Maternal asthma [22, 23], maternal hypertension in pregnancy [22] and smoking in pregnancy [22, 24] are among risk factors that have been associated with impaired lung function observed as lower tPTEF/tE values in offspring. A tPTEF/tE ≤0.25 is associated with obstructive lung disease, while values ≥0.30 are usually considered normal [1, 3, 7, 21, 25, 26] and higher ratios are unlikely to represent improved health. Previous studies have shown lung function differences between girls and boys, with infant tPTEF/tE values tending to be higher in girls [6, 23, 27].

Tidal volume (VT) increases after birth [28, 29], with lower volumes in early infancy observed with prematurity [30] and lung hypoplasia [31]. While most studies exploring lung function in infancy have been performed in sleeping or sedated infants, both tPTEF/tE and VT seem to be higher in the awake compared to the sleeping state [32].

In the quest to identify modifiable factors during pregnancy that may impact infant lung health, here, we hypothesise that PA positively influences infant lung function and that lack of PA may be associated with lower lung function. The aim of the present study was therefore to determine, in a large cohort of infants from a general population, whether self-reported maternal PA in the first half of pregnancy is associated with infant lung function at 3 months of age primarily as lower lung function by tPTEF/tE <0.25 and, secondarily, by VT corrected for body weight (in kilograms).

Subjects and methods

Study design and setting

3-month-old infants with available lung function measurements and information on maternal PA in the first half of pregnancy from the Preventing Atopic Dermatitis and Allergies in Children (PreventADALL) cohort were included in this prospective observational study (figure 1). The PreventADALL study, described in detail elsewhere [33], is a Scandinavian general population-based mother–child birth cohort study including 2394 antenatally recruited mother–child pairs. Pregnant women planning to give birth at Oslo University Hospital or Østfold Hospital Trust, Norway, or in the region of Stockholm, Sweden, were eligible for participation. From December 2014 to October 2016, 2697 women at approximately 18 weeks of pregnancy (range 15.7–22.7 weeks) were recruited. Their healthy singletons or twins, born at ≥35.0 gestational weeks, were included at birth.

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Study population. The present study population includes all 812 infants from the Preventing Atopic Dermatitis and Allergies in Children (PreventADALL) cohort with a successful tidal flow–volume (TFV) measurement in the awake state at 3 months of age and available information on maternal physical activity in the first half of pregnancy. To ensure independency of all participants, the second-born twin was consecutively excluded.

Informed consent was signed by the mothers at recruitment and by both parents at birth. The study was approved by the regional committees for medical and health research ethics in Norway (2014/518) and Sweden (2014/2242–31/4), and registered at www.clinicaltrials.gov (identifier number NCT02449850).

Participants

In this substudy, we included all 812 3-month-old infants with a successful TFV measure of lung function in the awake state and available information on self-reported maternal PA in the first half of pregnancy. Lung function was measured at the Oslo and Stockholm study sites. Except for somewhat higher gestational age (GA) at birth, a higher rate of breastfeeding and less exposure to maternal use of nicotine after the first few weeks of pregnancy, the included infants were similar to the remaining infants (n=1582) from the PreventADALL cohort (table 1). The mothers of the included, compared to the remaining, infants were slightly older, had lower pre-pregnancy body mass index (BMI) and weight gain in the first half of pregnancy, and more were nullipara and highly educated, in line with previously described differences between the PreventADALL study sites [33]. Lung function measurements missing, unsuccessful or performed in the sleeping state were the main reasons for exclusion from the present study.

View this table:
  • View inline
  • View popup
TABLE 1

Baseline characteristics of the 812 infants included in the present study and the 1582 remaining infants from the Preventing Atopic Dermatitis and Allergies in Children (PreventADALL) mother–child birth cohort

Methods

Maternal PA in the first half of pregnancy was self-reported using electronic questionnaires sent to the mothers in relation to study recruitment. They answered how frequently they had performed different types of activities (strolling, brisk walking, jogging, bicycling, strength training, aerobics, skiing, ballgames, swimming, horse riding, yoga/Pilates and other types of PA) so far in their pregnancy. The usual intensity (low, moderate or high) and duration (<30 min, 30–60 min, 1–2 h or >2 h) of exercise was also reported. Low intensity was defined as “no sweating or shortness of breath”, moderate as “sweaty and some shortness of breath” and high as “very sweaty and very heavy breathing”. Based on all available answers, the general activity level for 2349 women in the PreventADALL cohort was estimated [20]. We defined women reporting PA of moderate or high intensity as “active” and calculated their minimum number of active minutes per week by multiplying the minimum number of sessions per week with their usual duration of exercise. Women with active minutes per week at or above the median of 120 min were further defined as “highly active” and those below the median as “fairly active”. Women reporting only low intensity or no exercise at all were defined as “inactive”. For further information, see the supplementary material.

Additionally, the questionnaire included questions on socioeconomic factors, health and lifestyle as well as family history of atopic diseases.

TFV loops were measured in calm infants by trained study personnel at the 3-month follow-up visit, using the Exhalyzer D (Eco Medics, Duernten, Switzerland) equipment [35]. An appropriately sized face mask was connected to the ultrasonic flow head with a dead space reducer, a filtering spirette and a carbon dioxide adapter with a Capnostat carbon dioxide sensor in between. The face mask was held tight over the infant's nose and mouth while as many TFV loops as possible were recorded (supplementary table S1). All infants included in the present study were awake, with measurements performed with head and neck on the midline in the supine position on a firm pillow on their caregiver's lap or in a stroller/bed. A procedure for selection of TFV loops in awake infants was tested and validated prior to analyses, with details on visual inspection and loop selection reported elsewhere [35]. Mean values for tPTEF/tE, VT and respiratory rate were registered for each infant.

Information about the delivery and the newborn was taken from electronic hospital records. At 3 months post partum, the mothers answered questions about their infants' health and nutrition. Infant weight and length were measured at the follow-up visit by trained study personnel.

Variables

Primary outcome

The primary outcome, lower lung function, was defined as a tPTEF/tE ratio <0.25.

Secondary outcome

The secondary outcome, VT corrected for body weight, was recorded as a continuous variable.

Exposure

The maternal general activity level was based on self-reported intensity of exercise in the first half of pregnancy [20]. Primarily, we compared infants of inactive mothers to those of all active mothers, and secondarily, to infants of active mothers in the subgroups of fairly active and highly active.

Covariates

All multivariable regression models were adjusted for maternal age, education, parity, pre-pregnancy BMI, in utero nicotine exposure and parental atopy. These potential confounders of the association between maternal PA in pregnancy and infant lung function were identified using a directed acyclic graph (DAG) [36] prior to statistical analyses (supplementary figure S1). Only conditions arising before the first half of pregnancy and potentially affecting both the exposure and outcome could be considered as confounders and adjusted for in the regression models.

Statistical analysis

Continuous variables are presented as mean (range), mean±sd or mean (95% CI). Categorical variables are presented as n (%).

We used logistic regression models to analyse the association between maternal general activity level and tPTEF/tE <0.25, presented as odds ratios with 95% confidence intervals and p-values. For the continuous VT corrected for body weight outcome, linear regression models are presented with regression coefficients (:Embedded Image estimate), R2, 95% confidence intervals and p-values.

To assess a potential interaction with infant sex, we added the interaction term “maternal PA×infant sex” to our regression models.

We compared the infants included in the present study to all remaining infants in the PreventADALL cohort with the independent sample t-test (continuous variables), the Chi-squared test (nominal variables) or the Mann–Whitney U-test (ordinal variables). p-values <0.05 were regarded as significant.

IBM SPSS statistics version 27, RStudio version 4.1.0 and Microsoft Excel 2016 were used for statistical analyses.

Results

The 812 infants (48.8% girls) included in the present study were born at mean (range) GA of 40.1 (35.3–42.3) weeks (table 1). Their mean (range) age at the time of lung function testing was 93 (57–137) days and their weight, 6.3 (4.4–8.9) kg.

Approximately one third of the mothers (290 (35.7%) out of 812) were defined as inactive in the first half of pregnancy. Of the 522 (64.3% out of 812) active mothers, 224 (27.6% out of 812) were fairly active and 298 (36.7% out of 812) were highly active.

Mean±sd (range) tPTEF/tE for the included infants was 0.39±0.08 (0.19–0.63), with the distribution shown in figure 2a. Few had low values; while 47 infants (5.8%) had a tPTEF/tE <0.25, only five (0.6%) had values <0.20. The mean±sd number of TFV loops was 21±14 per infant (supplementary table S1).

FIGURE 2
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2

Histograms showing the distribution of the infant ratio of time to peak tidal expiratory flow to expiratory time (tPTEF/tE) in a) all included infants (n=812) and b) infants of inactive (n=290) compared to all active (n=522) mothers, presented with partly overlapping bars. While the y-axis in a) shows frequency, the two overlapping histograms in b) have percentage on the y-axis to enable comparison of the distribution of infant tPTEF/tE in subgroups of different size.

The mean±sd tPTEF/tE was similar among infants of inactive and active mothers: 0.387±0.09 compared to 0.393±0.08 (figure 3 and supplementary table S2); however, as shown in the histogram in figure 2b, the tPTEF/tE distribution appears to be different in the lower tail between the two groups and tPTEF/tE variability greater among infants of inactive mothers.

FIGURE 3
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3

Infant ratio of time to peak tidal expiratory flow to expiratory time (tPTEF/tE) at 3 months of age according to maternal general activity level, shown for infants of a) inactive and active mothers, and b) inactive, fairly active and highly active mothers. Mean tPTEF/tE for infants of inactive and active mothers was compared with the independent sample t-test (p=0.321), and for infants of inactive, fairly active and highly active mothers, with one-way ANOVA (p=0.594). No statistically significant difference was observed between the groups. Symbols represent means and whiskers represent 95% confidence intervals.

Infants of inactive mothers had significantly higher odds of having a tPTEF/tE <0.25 compared to infants of all active mothers as well as when compared to the infants of fairly active mothers only, in both univariable and multivariable regression models (table 2).

View this table:
  • View inline
  • View popup
TABLE 2

The association between maternal general activity level in the first half of pregnancy and the infant ratio of time to peak tidal expiratory flow to expiratory time (tPTEF/tE) <0.25, analysed with logistic regression models

The mean±sd VT corrected for body weight for all included infants was 7.05±2.12 mL·kg−1, with no significant difference between infants of inactive mothers compared to those of all active mothers (results not shown). However, when active mothers were subdivided into fairly and highly active, VT corrected for body weight differed significantly between the three groups (figure 4a and supplementary table S3a). Infants of highly active mothers had the lowest mean±sd VT corrected for body weight of 6.79±2.05 mL·kg−1, which was significantly lower than that of the infants of fairly active mothers (7.25±2.13 mL·kg−1, p=0.035), while they did not differ significantly from the infants of inactive mothers (7.17±2.16 mL·kg−1). A significant association was observed between high maternal activity and lower infant VT corrected for body weight in both univariable and multivariable models (table 3).

FIGURE 4
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4

Infant a) tidal volume (VT) corrected for body weight and b) respiratory rate at 3 months of age according to maternal general activity level in three categories. a) Mean VT corrected for body weight was compared between groups with one-way ANOVA (p=0.023). Mean VT corrected for body weight differed significantly between infants of fairly active and highly active mothers (mean difference 0.47 mL·kg−1, 95% CI 0.026–0.905 mL·kg−1; p=0.035). b) Mean respiratory rate was compared between groups with one-way ANOVA (p=0.053). Mean respiratory rate differed significantly between infants of highly active and fairly active mothers (mean difference 2.84, 95% CI 0.09–5.59 breaths per min; p=0.041). Symbols represent means and whiskers represent 95% confidence intervals.

View this table:
  • View inline
  • View popup
TABLE 3

The association between maternal general activity level in the first half of pregnancy and infant tidal volume corrected for body weight, analysed with linear regression models

There was no significant interaction between maternal PA in the first half of pregnancy and infant sex, and neither did the association between maternal PA and infant lung function change by including infant sex in the regression models (results not shown).

Discussion

Maternal PA in the first half of pregnancy was significantly associated with lung function in 812 healthy awake 3-month-old infants born after ≥35.0 weeks of pregnancy. Infants of physically inactive mothers were more likely to have low tPTEF/tE values, with twice the odds of having a tPTEF/tE <0.25 compared to infants of active mothers. High maternal activity was associated with lower VT corrected for body weight.

The significant association between maternal inactivity in the first half of pregnancy and lower tPTEF/tE at 3 months of age is a novel finding, although studies that have examined the fetus during maternal exercise may support our results [37, 38]. Fetal breathing movements, observed as early as the first trimester, are important for development of the lungs and the respiratory system [8, 39]. While maternal exercise can transiently affect both fetal breathing and body movements [37, 38], little is known about potential associations between breathing movements in the fetus and postnatal lung function. In addition, an increased variability in fetal heart rate during maternal exercise may, together with higher blood flow in the umbilical cord and the placental circulation, indicate an improved in utero environment in active women and lower the risk of fetal adverse outcomes [38].

Higher odds of low tPTEF/tE were observed among infants born to inactive mothers compared to all active and to fairly active mothers. We explored potential associations of PA on lung function values within a normal, healthy infant population, and based upon clinically relevant cut-off values from previous studies, we chose tPTEF/tE <0.25 to represent low lung function [1, 3, 7, 25, 26]. Future studies of the PreventADALL cohort may reveal whether maternal inactivity in the first half of pregnancy is associated with an increased risk of obstructive lung diseases in the offspring. Infants of highly active mothers did not have significantly lower odds of having a low tPTEF/tE, suggesting that the observed association did not depend on the most active mothers.

The present study is based on maternal PA reported around mid-pregnancy, while complications such as excessive gestational weight gain, hypertension and diabetes, improvable and partly preventable [13, 15, 16] by PA, often arise later. One may speculate that the higher prevalence of these pregnancy complications in physically inactive women could partly explain the association with lower infant tPTEF/tE. To explore the association between maternal PA level in the first half of pregnancy and infant lung function we have only adjusted for variables potentially affecting both the exposure and the outcome. Thus, neither pregnancy complications nor infant factors such as sex, GA, birth weight or breastfeeding [6, 8, 23, 27, 30, 40], previously shown to affect lung function, were regarded as potential confounders.

While VT corrected for body weight was similar among infants of inactive and active mothers overall, a significantly lower VT corrected for body weight was observed among infants of highly active compared to fairly active mothers. We are unaware of similar findings reported elsewhere. The potential reasons for the association between high-level PA and lower VT corrected for body weight are not clear and could not be fully explained by the slightly higher respiratory rate observed in infants of highly active mothers (figure 4b and supplementary material). Although weight-bearing exercise in the supine position and late in pregnancy has been associated with transient fetal bradycardia, reduced uterine blood flow and reduced fetoplacental growth, increasing the risk of fetal growth restriction [38], our study cannot elucidate such potential mechanisms. However, although not significant, infants of highly active mothers had the smallest placentas and lowest birthweight, with the subsequent highest weight gain until 3 months of age (supplementary figure S2b), in line with previous findings of lower birthweight in relation to vigorous maternal exercise and exercise during pregnancy in previously inactive women [12, 41]. Low birth weight and high infant weight gain are associated with asthma and lower lung function values in childhood [40]. Important stages of airway development complete during the second trimester [6, 8] while the third trimester of pregnancy is mainly associated with fetal growth and weight gain. It is possible that high activity levels in late pregnancy, causing slower fetal growth, could lead to discrepancy in airway development and lung growth that may partly explain the lowest VT corrected for body weight and normal tPTEF/tE in infants of highly active women. A smaller lung size relative to the airway calibre results in higher expiratory flow and tPTEF/tE [6] and even though a “catch-up” body growth is observed, lung growth might not catch up as fast, reflected by lower VT corrected for body weight at 3 months of age.

The large group of healthy infants, with lung function measured in the awake state at a relatively similar age, is a strength of this study. The general activity level was slightly higher for the mothers of the infants included in the present study compared with the whole PreventADALL cohort [20] and some maternal differences related to study sites were observed [33]. Nevertheless, we believe our results are representative of the general Scandinavian population. Prior to analyses, we identified confounders by constructing a DAG based on available knowledge. Apart from nonsignificantly lower birthweight and higher weight gain in the first 3 months of life, no differences in infant characteristics according to maternal PA level were observed, supporting our DAG and findings.

Due to the design of the study, all information on maternal PA was self-reported, with certain limitations arising from the questionnaire. Although our analyses are based on an estimate of active minutes per week, as the women were not asked about the total weekly duration or frequency of exercise, we believe that the classification of active women into fairly and highly active is reasonable. In this study, we addressed the role of PA in the first half of pregnancy for early fetal respiratory development, using detailed PA data collected at enrolment. Information on maternal PA in the second half of pregnancy was limited to changes in PA habits from mid-pregnancy until 34 weeks gestation and after this time no information on maternal PA was available. In addition, to account for potential pregnancy complications that may impact on activity levels, more likely to be present in the last part of pregnancy, would necessitate a larger cohort than ours.

Conclusion

Maternal PA in pregnancy was significantly associated with infant lung function, with higher odds of low tPTEF/tE in infants of inactive compared to active mothers, and an association between high maternal activity and lower VT. The observed association between maternal inactivity and lower infant lung function may have clinical implications, adding to the importance of advising and supporting pregnant women to adhere to guidelines on PA during pregnancy. Nevertheless, there might be confounders for which we have not adjusted and, potentially, maternal PA level could be a proxy for general health or an unknown factor associated with lung function in the offspring.

Supplementary material

Supplementary Material

Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.

Supplementary material 00172-2022.SUPPLEMENT

Acknowledgements

We sincerely thank all our study participants and their families. We thank all those who contributed to the planning of the study, recruitment of participants, clinical examinations and biological sampling, as well as those facilitating and running the study, especially: Hilde Aaneland (Division of Paediatric and Adolescent Medicine, Oslo University Hospital, and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway), Ann Berglind (Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden), Åshild Wik Despriée (VID Specialized University, Oslo, Norway), Kim M.A. Endre (Department of Dermatology and Venereology, Oslo University Hospital, and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway), Berit Granum (Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway), Malén Gudbrandsgard (Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway), Gunilla Hedlin (Department of Women's and Children's Health, Karolinska Institutet, and Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden), Katarina Hilde (Division of Obstetrics and Gynaecology, Oslo University Hospital, and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway), Ina Kreyberg (Division of Paediatric and Adolescent Medicine, Oslo University Hospital, and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway), Live S. Nordhagen (Division of Paediatric and Adolescent Medicine, Oslo University Hospital; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo; and VID Specialized University, Oslo, Norway), Carina M. Saunders (Division of Paediatric and Adolescent Medicine, Oslo University Hospital, and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway), Birgitte Kordt Sundet (Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, and Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway), Cilla Söderhäll (Department of Women's and Children's Health, Karolinska Institutet, and Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden), Sandra Ganrud Tedner (Department of Women's and Children's Health, Karolinska Institutet, and Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden), Ellen Tegnerud (Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden), Magdalena R. Værnesbranden (Department of Obstetrics and Gynaecology, Østfold Hospital Trust, Kalnes, and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway), Johanna Wiik (Department of Obstetrics and Gynaecology, Østfold Hospital Trust, Kalnes, Norway; Department of Obstetrics and Gynaecology, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University; and Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden) and, in memoriam, Kai-Håkon Carlsen (Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway).

Footnotes

  • Provenance: Submitted article, peer reviewed.

  • This study is registered at www.clinicaltrials.gov with identifier number NCT02449850.

  • The study was performed within ORAACLE (the Oslo Research Group of Asthma and Allergy in Childhood; the Lung and Environment).

  • Conflict of interest: M. LeBlanc reports personal fees from MSD, outside the submitted work. E.M. Rehbinder reports personal fees from Sanofi-Genzyme, Novartis, Leo-Pharma, Perrigo, and The Norwegian Asthma and Allergy Association, outside the submitted work. The other authors have no financial relationships relevant to this article to disclose.

  • Support statement: This study was a part of a PhD project and H.K. Gudmundsdóttir has received funding as a doctoral research fellow from the University of Oslo, Norway. The PreventADALL study was supported by a number of public and private funding bodies with no influence on design, conduct or analyses. The PreventADALL study has received funding from the following sources: The Regional Health Board South East, The Norwegian Research Council, Oslo University Hospital, The University of Oslo, Health and Rehabilitation Norway, The Foundation for Healthcare and Allergy Research in Sweden (Vårdalstiftelsen), The Swedish Asthma and Allergy Association's Research Foundation, The Swedish Research Council – the Initiative for Clinical Therapy Research, The Swedish Heart–Lung Foundation, SFO-V Karolinska Institutet, Østfold Hospital Trust, by unrestricted grants from the Norwegian Association of Asthma and Allergy, The Kloster foundation, Thermo-Fisher, Uppsala, Sweden (through supplying allergen reagents) and Fürst Medical Laboratory, Oslo, Norway (through performing IgE analyses), Norwegian Society of Dermatology and Venerology, Arne Ingels Legat, Region Stockholm (ALF-project and individual grants), Forte, Swedish Order of Freemasons Foundation Barnhuset, The Sven Jerring Foundation, The Hesselman foundation, The Magnus Bergwall foundation, The Konsul Th.C. Bergh Foundation, The Swedish Society of Medicine, The King Gustaf V 80th Birthday Foundation, KI grants, The Cancer and Allergy Foundation, The Pediatric Research Foundation at Astrid Lindgren Children's Hospital, The Samaritan Foundation for Pediatric research, Barnestiftelsen at Oslo University Hospital, Roche, and The Frithjof Nansen Institute. Funding information for this article has been deposited with the Crossref Funder Registry.

  • Received April 8, 2022.
  • Accepted July 14, 2022.
  • Copyright ©The authors 2022
http://creativecommons.org/licenses/by-nc/4.0/

This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org

References

  1. ↵
    1. Lodrup Carlsen KC,
    2. Carlsen KH,
    3. Nafstad P, et al.
    Perinatal risk factors for recurrent wheeze in early life. Pediatr Allergy Immunol 1999; 10: 89–95. doi:10.1034/j.1399-3038.1999.00028.x
    OpenUrlCrossRefPubMed
    1. Dezateux C,
    2. Stocks J,
    3. Dundas I, et al.
    Impaired airway function and wheezing in infancy: the influence of maternal smoking and a genetic predisposition to asthma. Am J Respir Crit Care Med 1999; 159: 403–410. doi:10.1164/ajrccm.159.2.9712029
    OpenUrlCrossRefPubMed
  2. ↵
    1. Haland G,
    2. Carlsen KC,
    3. Sandvik L, et al.
    Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med 2006; 355: 1682–1689. doi:10.1056/NEJMoa052885
    OpenUrlCrossRefPubMed
  3. ↵
    1. Guerra S,
    2. Lombardi E,
    3. Stern DA, et al.
    Fetal origins of asthma: a longitudinal study from birth to age 36 years. Am J Respir Crit Care Med 2020; 202: 1646–1655. doi:10.1164/rccm.202001-0194OC
    OpenUrlPubMed
  4. ↵
    1. Stern DA,
    2. Morgan WJ,
    3. Wright AL, et al.
    Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 2007; 370: 758–764. doi:10.1016/S0140-6736(07)61379-8
    OpenUrlCrossRefPubMed
  5. ↵
    1. Boezen HM,
    2. Jansen DF,
    3. Postma DS
    . Sex and gender differences in lung development and their clinical significance. Clin Chest Med 2004; 25: 237–245. doi:10.1016/j.ccm.2004.01.012
    OpenUrlCrossRefPubMed
  6. ↵
    1. Young S,
    2. Arnott J,
    3. Le Souef PN, et al.
    Flow limitation during tidal expiration in symptom-free infants and the subsequent development of asthma. J Pediatr 1994; 124: 681–688. doi:10.1016/s0022-3476(05)81355-1
    OpenUrlCrossRefPubMed
  7. ↵
    1. Stocks J,
    2. Hislop A,
    3. Sonnappa S
    . Early lung development: lifelong effect on respiratory health and disease. Lancet Respir Med 2013; 1: 728–742. doi:10.1016/s2213-2600(13)70118-8
    OpenUrlPubMed
  8. ↵
    1. Evenson KR,
    2. Barakat R,
    3. Brown WJ, et al.
    Guidelines for physical activity during pregnancy: comparisons from around the world. Am J Lifestyle Med 2014; 8: 102–121. doi:10.1177/1559827613498204
    OpenUrlCrossRefPubMed
  9. ↵
    1. ACOG Committee
    . Physical activity and exercise during pregnancy and the postpartum period: ACOG Committee opinion, number 804. Obstet Gynecol 2020; 135: e178–e188. doi:10.1097/aog.0000000000003772
    OpenUrlCrossRefPubMed
  10. ↵
    1. Szymanski LM,
    2. Satin AJ
    . Exercise during pregnancy: fetal responses to current public health guidelines. Obstet Gynecol 2012; 119: 603–610. doi:10.1097/AOG.0b013e31824760b5
    OpenUrlCrossRefPubMed
  11. ↵
    1. Davenport MH,
    2. Meah VL,
    3. Ruchat SM, et al.
    Impact of prenatal exercise on neonatal and childhood outcomes: a systematic review and meta-analysis. Br J Sports Med 2018; 52: 1386–1396. doi:10.1136/bjsports-2018-099836
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Di Mascio D,
    2. Magro-Malosso ER,
    3. Saccone G, et al.
    Exercise during pregnancy in normal-weight women and risk of preterm birth: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2016; 215: 561–571. doi:10.1016/j.ajog.2016.06.014
    OpenUrlPubMed
  13. ↵
    1. Magro-Malosso ER,
    2. Saccone G,
    3. Di Mascio D, et al.
    Exercise during pregnancy and risk of preterm birth in overweight and obese women: a systematic review and meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand 2017; 96: 263–273. doi:10.1111/aogs.13087
    OpenUrlPubMed
  14. ↵
    1. Davenport MH,
    2. Ruchat SM,
    3. Poitras VJ, et al.
    Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: a systematic review and meta-analysis. Br J Sports Med 2018; 52: 1367–1375. doi:10.1136/bjsports-2018-099355
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Vargas-Terrones M,
    2. Nagpal TS,
    3. Barakat R
    . Impact of exercise during pregnancy on gestational weight gain and birth weight: an overview. Braz J Phys Ther 2019; 23: 164–169. doi:10.1016/j.bjpt.2018.11.012
    OpenUrl
  16. ↵
    1. Davenport MH,
    2. McCurdy AP,
    3. Mottola MF, et al.
    Impact of prenatal exercise on both prenatal and postnatal anxiety and depressive symptoms: a systematic review and meta-analysis. Br J Sports Med 2018; 52: 1376–1385. doi:10.1136/bjsports-2018-099697
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Owe KM,
    2. Nystad W,
    3. Stigum H, et al.
    Exercise during pregnancy and risk of cesarean delivery in nulliparous women: a large population-based cohort study. Am J Obstet Gynecol 2016; 215: 791.e1–791.e13. doi:10.1016/j.ajog.2016.08.014
    OpenUrlPubMed
  18. ↵
    1. Norwegian Directorate of Health
    . Fysisk aktivitet i forebygging og behandling: 3. Gravide [Physical activity in prevention and treatment: 3. Pregnant women]. www.helsedirektoratet.no/faglige-rad/fysisk-aktivitet-i-forebygging-og-behandling/gravide Date last updated: 9 May 2022. Date last accessed: 23 September 2022.
  19. ↵
    1. Carlsen OCL,
    2. Gudmundsdóttir HK,
    3. Bains KES, et al.
    Physical activity in pregnancy: a Norwegian–Swedish mother–child birth cohort study. AJOG Global Reports 2021; 1: 100002. doi:10.1016/j.xagr.2020.100002
    OpenUrl
  20. ↵
    1. Hevroni A,
    2. Goldman A,
    3. Blank-Brachfeld M, et al.
    Use of tidal breathing curves for evaluating expiratory airway obstruction in infants. J Asthma 2018; 55: 1331–1337. doi:10.1080/02770903.2017.1414234
    OpenUrl
  21. ↵
    1. Stick SM,
    2. Burton PR,
    3. Gurrin L, et al.
    Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet 1996; 348: 1060–1064. doi:10.1016/s0140-6736(96)04446-7
    OpenUrlCrossRefPubMed
  22. ↵
    1. de Gouveia Belinelo P,
    2. Collison AM,
    3. Murphy VE, et al.
    Maternal asthma is associated with reduced lung function in male infants in a combined analysis of the BLT and BILD cohorts. Thorax 2021; 76: 996–1001. doi:10.1136/thoraxjnl-2020-215526
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Lødrup Carlsen KC,
    2. Jaakkola JJ,
    3. Nafstad P, et al.
    In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J 1997; 10: 1774–1779. doi:10.1183/09031936.97.10081774
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Morris MJ,
    2. Lane DJ
    . Tidal expiratory flow patterns in airflow obstruction. Thorax 1981; 36: 135–142. doi:10.1136/thx.36.2.135
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Martinez FD,
    2. Morgan WJ,
    3. Wright AL, et al.
    Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988; 319: 1112–1117. doi:10.1056/nejm198810273191702
    OpenUrlCrossRefPubMed
  26. ↵
    1. Gray D,
    2. Willemse L,
    3. Visagie A, et al.
    Determinants of early-life lung function in African infants. Thorax 2017; 72: 445–450. doi:10.1136/thoraxjnl-2015-207401
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Anık A,
    2. Öztürk S,
    3. Erge D, et al.
    Tidal breath in healthy term newborns: an analysis from the 2nd to the 30th days of life. Pediatr Pulmonol 2021; 56: 274–282. doi:10.1002/ppul.25125
    OpenUrl
  28. ↵
    1. Kraemer R,
    2. Smith HJ,
    3. Matthys H
    . Normative reference equations of airway dynamics assessed by whole-body plethysmography during spontaneous breathing evaluated in infants, children, and adults. Physiol Rep 2021; 9: e15027. doi:10.14814/phy2.15027
    OpenUrl
  29. ↵
    1. Beretta F,
    2. Lavizzari A,
    3. Pesenti N, et al.
    Effect of human milk and other neonatal variables on lung function at three months corrected age. Pediatr Pulmonol 2021; 56: 3832–3838. doi:10.1002/ppul.25625
    OpenUrl
  30. ↵
    1. Mank A,
    2. Carrasco Carrasco C,
    3. Thio M, et al.
    Tidal volumes at birth as predictor for adverse outcome in congenital diaphragmatic hernia. Arch Dis Child Fetal Neonatal Ed 2020; 105: 248–252. doi:10.1136/archdischild-2018-316504
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Lodrup KC,
    2. Mowinckel P,
    3. Carlsen KH
    . Lung function measurements in awake compared to sleeping newborn infants. Pediatr Pulmonol 1992; 12: 99–104.
    OpenUrlPubMed
  32. ↵
    1. Lodrup Carlsen KC,
    2. Rehbinder EM,
    3. Skjerven HO, et al.
    Preventing Atopic Dermatitis and ALLergies in Children – the PreventADALL study. Allergy 2018; 73: 2063–2070. doi:10.1111/all.13468
    OpenUrlCrossRef
    1. Kreyberg I,
    2. Bains KES,
    3. Carlsen KH, et al.
    Stopping when knowing: use of snus and nicotine during pregnancy in Scandinavia. ERJ Open Res 2019; 5: 00197-2018. doi:10.1183/23120541.00197-2018
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Bains KES,
    2. Gudmundsdóttir HK,
    3. Färdig M, et al.
    Infant lung function: criteria for selecting tidal flow–volume loops. ERJ Open Res 2022; 8: 00165-2022. doi:10.1183/23120541.00165-2022
    OpenUrlAbstract/FREE Full Text
  34. ↵
    1. Textor J,
    2. Hardt J,
    3. Knüppel S
    . DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology 2011; 22: 745. doi:10.1097/EDE.0b013e318225c2be
    OpenUrlPubMed
  35. ↵
    1. Sussman D,
    2. Lye SJ,
    3. Wells GD
    . Impact of maternal physical activity on fetal breathing and body movement – a review. Early Hum Dev 2016; 94: 53–56. doi:10.1016/j.earlhumdev.2016.01.006
    OpenUrl
  36. ↵
    1. Bauer I,
    2. Hartkopf J,
    3. Kullmann S, et al.
    Spotlight on the fetus: how physical activity during pregnancy influences fetal health: a narrative review. BMJ Open Sport Exerc Med 2020; 6: e000658. doi:10.1136/bmjsem-2019-000658
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Harding R
    . Fetal pulmonary development: the role of respiratory movements. Equine Vet J Suppl 1997; 24: 32–39. doi:10.1111/j.2042-3306.1997.tb05076.x
    OpenUrlPubMed
  38. ↵
    1. den Dekker HT,
    2. Sonnenschein-van der Voort AM,
    3. de Jongste JC, et al.
    Early growth characteristics and the risk of reduced lung function and asthma: a meta-analysis of 25,000 children. J Allergy Clin Immunol 2016; 137: 1026–1035. doi:10.1016/j.jaci.2015.08.050
    OpenUrlCrossRef
  39. ↵
    1. Beetham KS,
    2. Giles C,
    3. Noetel M, et al.
    The effects of vigorous intensity exercise in the third trimester of pregnancy: a systematic review and meta-analysis. BMC Pregnancy Childbirth 2019; 19: 281. doi:10.1186/s12884-019-2441-1
    OpenUrlPubMed
PreviousNext
Back to top
Vol 8 Issue 4 Table of Contents
ERJ Open Research: 8 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Infant lung function and maternal physical activity in the first half of pregnancy
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Infant lung function and maternal physical activity in the first half of pregnancy
Hrefna Katrín Gudmundsdóttir, Oda C.L. Carlsen, Karen Eline Stensby Bains, Martin Färdig, Guttorm Haugen, Christine M. Jonassen, Marissa LeBlanc, Björn Nordlund, Eva Maria Rehbinder, Håvard O. Skjerven, Anne Cathrine Staff, Riyas Vettukattil, Karin C. Lødrup Carlsen
ERJ Open Research Oct 2022, 8 (4) 00172-2022; DOI: 10.1183/23120541.00172-2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Infant lung function and maternal physical activity in the first half of pregnancy
Hrefna Katrín Gudmundsdóttir, Oda C.L. Carlsen, Karen Eline Stensby Bains, Martin Färdig, Guttorm Haugen, Christine M. Jonassen, Marissa LeBlanc, Björn Nordlund, Eva Maria Rehbinder, Håvard O. Skjerven, Anne Cathrine Staff, Riyas Vettukattil, Karin C. Lødrup Carlsen
ERJ Open Research Oct 2022, 8 (4) 00172-2022; DOI: 10.1183/23120541.00172-2022
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Subjects and methods
    • Results
    • Discussion
    • Supplementary material
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Lung structure and function
  • Paediatric pulmonology
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original research articles

  • Hyperoxia improves exercise capacity in cardiopulmonary disease
  • MRI of bronchial artery dilatation in cystic fibrosis
  • Delineating associations of progressive PPFE in PF
Show more Original research articles

Lung function

  • Plasma proteins and lung function
  • Period and cohort effects
Show more Lung function

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society